Intralesional bleomycin: A treatment modality for conjunctival lymphangioma

4Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Lymphangioma is a benign hamartomatous lesion of vascular system which frequently involves orbit and ocular adnexa. A 35-year-old male patient presented with a subconjunctival mass extending from limbus to fornices. There was a history of recurrent swellings following episodes of upper respiratory tract infection. Bleomycin is an antineoplastic agent which acts on endothelial cells of the vascular channels, helps in collapsing the cystic cavity, and prevents its recurrence. We report a case where only bleomycin injection has been used intralesionally at multiple spots and patients have shown good cosmetic outcome without any recurrence noted after 1 year of follow-up.

Cite

CITATION STYLE

APA

Bansal, S., & Das, S. (2020). Intralesional bleomycin: A treatment modality for conjunctival lymphangioma. Oman Journal of Ophthalmology, 13(1), 43–45. https://doi.org/10.4103/ojo.OJO_44_2019

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free